Screening acute hiv infections among chinese men who have sex with men from voluntary counseling & testing centers

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Han, Xiaoxu ^a   Xu, Junjie ^a   Chu, Zhenxing ^a   Dai, Di ^a   Lu, Chunming ^b   Wang, Xu ^c   Zhao, Li ^d   Zhang, Cheng ^a   Ji, Yangtao ^a   Zhang, Hui ^a   Shang, Hong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Liaoning Center for Disease Control and Prevention   (China)

^c HIV and Sexually Transmitted Disease Prevention and Control Department   (China)

^d Anshan Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CHINESE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTERMETHOD COMPARISON; MALE; MALE HOMOSEXUAL; NUCLEIC ACID AMPLIFICATION; PATIENT COUNSELING; PROSPECTIVE STUDY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; VIRUS TRANSMISSION; WESTERN BLOTTING; ACUTE DISEASE; ASIAN; CHINA; COHORT ANALYSIS; COST BENEFIT ANALYSIS; COUNSELING; ECONOMICS; FOLLOW UP; HEALTH CARE FACILITY; HOMOSEXUALITY; MASS SCREENING; METHODOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; RISK FACTOR;

ACUTE DISEASE; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COHORT STUDIES; COST-BENEFIT ANALYSIS; COUNSELING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLOW-UP STUDIES; HEALTH FACILITIES; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MASS SCREENING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 83355168630     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028792     Document Type: Article

References (41)

1. Xu JJ, Zhang M, Brown K, Reilly K, Wang HL, et al. (2010) Syphilis and HIV Seroconversion Among a 12-Month Prospective Cohort of Men Who Have Sex With Men in Shenyang, China. Sexually Transmitted Diseases 37: 432-439.
2. Xiao Y, Sun JP, Li CM, Lu F, Allen KL, et al. (2010) Prevalence and Correlates of HIV and Syphilis Infections Among Men Who Have Sex With Men in Seven Provinces in China With Historically Low HIV Prevalence. Jaids-Journal of Acquired Immune Deficiency Syndromes 53: S66-S73.
3. Fisher M, Pao D, Brown AE, Sudarshi D, Gill ON, et al. (2010) Determinants of HIV-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approach. AIDS 24: 1739-1747.
4. Han M, Feng L-G, Jiang Y, Shen S, Ling H, et al. (2009) Surveillance on HIV-1 incidence among men who have sex with men in Chongqing, China, 2006-2008. Zhonghua Liu Xing Bing Xue Za Zhi 30: 878-881.
5. Guo HX, Wei JF, Yang HT, Huan XP, Tsui SKW, et al. (2009) Rapidly Increasing Prevalence of HIV and Syphilis and HIV-1 Subtype Characterization Among Men Who Have Sex With Men in Jiangsu, China. Sexually Transmitted Diseases 36: 120-125.
6. Lau JTF, Lin C, Hao C, Wu X, Gu J, (2011) Public health challenges of the emerging HIV epidemic among men who have sex with men in China. Public Health 125: 260-265.
7. van Griensven F, Varangrat A, Wimonsate W, Tanpradech S, Kladsawad K, et al. (2010) Trends in HIV Prevalence, Estimated HIV Incidence, and Risk Behavior Among Men Who Have Sex With Men in Bangkok, Thailand, 2003-2007. Jaids-Journal of Acquired Immune Deficiency Syndromes 53: 234-239.
8. National AIDS Programme. Report of the HIV sentinel sero-surveilance survey 2008-Myanmar Pyinmana Government of Myanmar (2009).
9. Brahmam GNV, Kodavallaa V, Rajkumar H, Rachakulla HK, Kallam S, et al. (2008) Sexual practices, HIV and sexually transmitted infections among self-identified men who have sex with men in four high HIV prevalence states of India. AIDS 22: S45-S57.
10. Baral S, Sifakis F, Peryshkina A, Deobald IMV, Masenior N, et al. (2011) Risks for HIV infection among gay, bisexual and other men who have sex with men(MSM) in Moscow and St. Petersburg, Russia. AIDS Res Hum Retroviruses.
11. Zhang B, Li X, Shi T, (2002) Preliminary Evaluation the numberof Men who have Sex with Men/bisexual population and humen immunodeficiency virus-1 prevallence Chinese Journal of STD/AIDS. Prevention and Control 8: 197-199.
12. Wang H, Zhang M, Hu Q, (2008) Prevalence of HIV/STD and risk behavior among men who have sex with men in Shenyang. Chinese Jouranl of Public Health 24: 995-997.
13. Rieder P, Joos B, von Wyl V, Kuster H, Grube C, et al. (2010) HIV-1 transmission after cessation of early antiretroviral therapy among men having sex with men. AIDS 24: 1177-1183.
14. Rieder P, Joos B, von Wyl V, Kuster H, Grube C, et al. (2010) HIV-1 transmission after cessation of early antiretroviral therapy among men having sex with men. AIDS 24: 1177-1183.
15. Pilcher CD, Fiscus SA, Nguyen TQ, Foust E, Wolf L, et al. (2005) Detection of acute infections during HIV testing in North Carolina. New England Journal of Medicine 352: 1873-1883.
16. Patel P, Mackellar D, Simmons P, Uniyal A, Gallagher K, et al. (2010) Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch Intern Med 170: 66-74.
17. Fall-Malick FZ, Bara AO, Lam M, Mint Beibacar M, Ba K, et al. (2010) [HIV sentinel surveillance of pregnant women in Mauritania from 2001 to 2007]. Bull Soc Pathol Exot 103: 243-245.
18. Ly TD, Laperche S, Courouce AM, (2001) Early detection of human immunodeficiency virus infection using third- and fourth-generation screening assays. European Journal of Clinical Microbiology & Infectious Diseases 20: 104-110.
19. Karim SS, Mlisana K, Kharsany AB, Williamson C, Baxter C, et al. (2007) Utilizing nucleic acid amplification to identify acute HIV infection. AIDS 21: 653-655.
20. Aprili G, Gandini G, Piccoli P, Bressan F, De Gironcoli M, et al. (2003) Detection of an early HIV-1 infection by HIV RNA testing in an Italian blood donor during the preseroconversion window period. Transfusion 43: 848-852.
21. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, et al. (2004) Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. New England Journal of Medicine 351: 760-768.
22. Scuracchio PSP, Poli MCC, Lemos MMM, Oliveira AG, Salles NA, et al. (2007) Detection of HIV-1 infection in blood donors during the immunological window period using the nucleic acid-amplification technology. Transfusion Medicine 17: 200-204.
23. Nubling CM, Heiden M, Chudy M, Kress J, Seitz R, et al. (2009) Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions. Transfusion 49: 1850-1858.
24. Tomono T, Brown F, (2002) Status of NAT screening for HCV, HIV and HBV: Experience in Japan. Advances in Transfusion Safety 2001: 29-39.
25. Hutchinson AB, Patel P, Sansom SL, Farnham PG, Sullivan TJ, et al. (2010) Cost-Effectiveness of Pooled Nucleic Acid Amplification Testing for Acute HIV Infection after Third-Generation HIV Antibody Screening and Rapid Testing in the United States: A Comparison of Three Public Health Settings. Plos Medicine 7.
26. Yazdanpanah Y, Sloan CE, Charlois-Ou C, Le Vu S, Semaille C, et al. (2010) Routine HIV Screening in France: Clinical Impact and Cost-Effectiveness. PLoS One 5.
27. Prabhu VS, Farnham PG, Hutchinson AB, Soorapanth S, Heffelfinger JD, et al. (2011) Cost-Effectiveness of HIV Screening in STD Clinics, Emergency Departments, and Inpatient Units: A Model-Based Analysis. PLoS One 6.
28. Patel P, Klausner JD, Bacon OM, Liska S, Taylor M, et al. (2006) Detection of acute HIV infections in high-risk patients in California. Jaids-Journal of Acquired Immune Deficiency Syndromes 42: 75-79.
29. Thorstensson R, Andersson S, Lindback S, Dias F, Mhalu F, et al. (1998) Evaluation of 14 commercial HIV-1/HIV-2 antibody assays using serum panels of different geographical origin and clinical stage including a unique seroconversion panel. Journal of Virological Methods 70: 139-151.
30. Zaaijer HL, Vonexeloehlers P, Kraaijeveld T, Altena E, Lelie PN, (1992) EARLY DETECTION OF ANTIBODIES TO HIV-1 BY 3RD-GENERATION ASSAYS. Lancet 340: 770-772.
31. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, et al. (2003) Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17: 1871-1879.
32. Palla P, Vatteroni ML, Vacri L, Maggi F, Baicchi U, (2006) HIV-1NAT minipool during the pre-seroconversion window period: detection of a repeat blood donor. Vox Sanguinis 90: 59-62.
33. Pao D, Fisher M, Hue S, Dean G, Murphy G, et al. (2005) Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections. AIDS 19: 85-90.
34. Brenner BG, Roger M, Routy JP, Moisi D, Ntemgwa M, et al. (2007) High rates of forward transmission events after acute/early HIV-1 infection. Journal of Infectious Diseases 195: 951-959.
35. Hollingsworth TD, Anderson RM, Fraser C, (2008) HIV-1 transmission, by stage of infection. Journal of Infectious Diseases 198: 687-693.
36. Sanders GD, Anaya HD, Asch S, Hoang T, Golden JF, et al. (2010) Cost-Effectiveness of Strategies to Improve HIV Testing and Receipt of Results: Economic Analysis of a Randomized Controlled Trial. Journal of General Internal Medicine 25: 556-563.
37. van Hulst M, Sagoe KWC, Vermande JE, van der Schaaf IP, Adriani W, et al. (2008) Cost-effectiveness of HIV screening of blood donations in Accra (Ghana). Value in Health 11: 809-819.
38. Lou J, Wu JH, Chen L, Ruan YH, Shao YM, (2009) A sex-role-preference model for HIV transmission among men who have sex with men in China. Bmc Public Health 9.
39. Lewis F, Hughes GJ, Rambaut A, Pozniak A, Leigh Brown AJ, (2008) Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med 5: e50.
40. Marks G, Crepaz N, Janssen RS, (2006) Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 20: 1447-1450.
41. Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, et al. (2006) The lifetime cost of current human immunodeficiency virus care in the United States. Med Care 44: 990-997.